PepsiCo has reported a 5.2 percent increase in net revenue in its second-quarter results of $20.22 billion, compared with $19.22 billion recorded for the same period last year, as it updates its full-year outlook.
Ramon Laguarta, Chairman and CEO of PepsiCo, their business momentum continued despite ongoing macroeconomic and geopolitical volatility and higher levels of inflation across our markets.
He added that they now expect their full-year organic revenue to increase 10 percent from 8 percent.
In the meantime, PepsiCo reported organic revenue growth of 13% and an operating profit for Q2 of 2022 of $2.1 billion.
Net revenue for its PepsiCo Beverages North America division fell by 1%. The company's Frito-Lay North America division reported net revenue growth of 14% while Quaker Foods North America saw net revenue growth of 17%.
Latin America was the region of PepsiCo that experienced the greatest growth, with a 23 percent increase in net revenue.


Synlait Milk Denies Fonterra, a2 Milk Takeover Talks
Nvidia Eyes $3 Billion Investment in SoftBank-Backed AI Data Center
Gold Prices Rise as Weak US Data and Hormuz Risks Boost Safe-Haven Demand
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal
NAB Q3 Cash Earnings Rise 2% as Lower Credit Charges Boost Profit
Aviva First-Half Operating Profit Jumps 24% as Direct Line Deal Boosts Growth
S&P 500 Retreats From Record High as AI Stocks Slide, Retail Sales Disappoint
Foreign U.S. Treasury Holdings Fall as Japan, UK and China Cut Positions
BSP Sees Philippine Inflation Easing, Keeps Policy Options Open
European Stocks Steady as U.S.-Iran War, Euro Zone Data Keep Investors Cautious
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support
US Stock Futures Mixed as Fed Rate Hike Bets Fade, AI Deals in Focus
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Morgan Stanley Sees Fed Holding Rates as U.S. Inflation Cools
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Dollar Slides as Soft U.S. Data Cuts Fed Rate Hike Bets
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case 



